NMN and NMN for Physical function / insulin sensitivity
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
NMN
An NAD+ precursor with real biomarker effects (NAD+ rises) and no proven clinical or longevity outcomes yet.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
NMN for Physical function / insulin sensitivity
Evidence grade C — Early, small
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | NMN | NMN for Physical function / insulin sensitivity |
|---|---|---|
| Physical function / insulin sensitivity | Evidence grade CSmall effectmixedEarly, small | Evidence grade CSmall effectmixedEarly, small |
Graded only in NMN
- Blood NAD+ Moderate effectEvidence grade B
Graded only in NMN for Physical function / insulin sensitivity
None — every outcome it grades is graded in both.
What each entry says about the other
- NMN for Physical function / insulin sensitivity’s entry · Goes with: Read the full NMN monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.